In a new paper published online in the Annals of the American Thoracic Society, researchers have been unable to produce two theorized subphenotypes of COVID-19 related acute respiratory distress ...
Preclinical studies suggest that exogenous surfactant may be of value in the treatment of the acute respiratory distress syndrome (ARDS), and two phase 2 clinical trials have shown a trend toward ...
The acute respiratory distress syndrome (ARDS) was originally defined as a clinical condition in 1967, although it had been recognized for years prior in soldiers dying of wartime injuries. [1] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results